Q2 2019 Predictive Oncology Inc Earnings Call Transcript
Good afternoon, and welcome to the Predictive Oncology Earnings Conference Call for the Second Quarter Ending June 30, 2019. (Operator Instructions)
Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A replay of the call will be available approximately 1 hour after the end of the call through July 31, 2019. I would now like to turn the conference over to Scott Gordon, President of CORE IR, the company's Investor Relations firm. Please go ahead, sir.
Thank you, Ben, and thank you for joining today's conference call to discuss Predictive Oncology's corporate developments and financial results for the second quarter ending June 30, 2019. With us today are Dr. Carl Schwartz, company's Chief Executive Officer; and Bob Myers, the company's Chief Financial Officer; Gerald Vardzel, President of Helomics; and Amelia Warner, COO of Helomics. At 5:15 p.m. Eastern time today,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |